{"entity":{"type":"insider","cik":"0001702237","url":"/insider/0001702237","json_url":"/insider/0001702237.json","name":"Kazma Michael D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2018-02-28","last":"2018-05-09","span_basis":"filed_date"},"name_variants":[{"name":"Kazma Michael D","source":"filing","n_filings":2,"first_seen":"2018-02-28","last_seen":"2018-05-09"}],"transactions":[{"id":6747651,"accession":"0001104659-18-031864","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-031864","line_url":"/filing/0001104659-18-031864#line-2","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Inspire Medical Systems, Inc.","issuer_ticker":"INSP","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":null,"owner_name":"Amzak Health Investors, LLC; Kazma Michael D; Hove Anders D","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":2000000.0,"total_display":"2,000,000.00","shares_owned_after":1497043.0,"shares_owned_after_display":"1,497,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-07","filed_date":"2018-05-09","scope":"insider"},{"id":6499128,"accession":"0001213900-18-002426","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-18-002426","line_url":"/filing/0001213900-18-002426#line-3","is_derivative":false,"issuer_cik":"0001565981","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001565981","owner_cik":null,"owner_name":"Amzak Capital Management, LLC; Kazma Michael D; Kazma Gerald J","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value of $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80880.0,"shares_display":"80,880","price_per_share":8.357,"price_display":"8.36","price_state":"stated","total_value":675914.16,"total_display":"675,914.16","shares_owned_after":175211.0,"shares_owned_after_display":"175,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-27","filed_date":"2018-02-28","scope":"insider"},{"id":6499126,"accession":"0001213900-18-002426","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-18-002426","line_url":"/filing/0001213900-18-002426#line-2","is_derivative":false,"issuer_cik":"0001565981","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001565981","owner_cik":null,"owner_name":"Amzak Capital Management, LLC; Kazma Michael D; Kazma Gerald J","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value of $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5901.0,"shares_display":"5,901","price_per_share":8.263,"price_display":"8.26","price_state":"stated","total_value":48759.963,"total_display":"48,759.96","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-27","filed_date":"2018-02-28","scope":"insider"},{"id":6499124,"accession":"0001213900-18-002426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-002426","line_url":"/filing/0001213900-18-002426#line-1","is_derivative":false,"issuer_cik":"0001565981","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001565981","owner_cik":null,"owner_name":"Amzak Capital Management, LLC; Kazma Michael D; Kazma Gerald J","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value of $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":16500.0,"total_display":"16,500.00","shares_owned_after":256091.0,"shares_owned_after_display":"256,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-26","filed_date":"2018-02-28","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001609550","name":"Inspire Medical Systems, Inc.","url":"/issuer/0001609550","role":"Ten percent owner","n_filings":1,"first_seen":"2018-05-09","last_seen":"2018-05-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001587221","name":"Zosano Pharma Corp","url":"/issuer/0001587221","role":"Ten percent owner","n_filings":1,"first_seen":"2018-02-28","last_seen":"2018-02-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001702237","retrieved_at":"2026-08-20T23:36:03+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}